Genetics of innate immunity and UTI susceptibility

Nature Reviews Urology

Volumn 8, Issue 8, 2011, Pages 449-468

  Ragnarsdóttir, Bryndís ^a   Lutay, Nataliya ^a   Grönberg Hernandez, Jenny ^a   Köves, Bela ^a   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTIBIOTIC AGENT; BETA INTERFERON; CATHELICIDIN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; INTERFERON REGULATORY FACTOR 3; MYELOID DIFFERENTIATION FACTOR 88; TAMM HORSFALL GLYCOPROTEIN; TIRAP PROTEIN; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ACUTE PYELONEPHRITIS; ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ANTIGEN RECOGNITION; ASYMPTOMATIC BACTERIURIA; BACTERIAL VIRULENCE; CELL INVASION; DISEASE MODEL; ESCHERICHIA COLI; FIMBRIA; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INCIDENCE; INFECTION RATE; INFECTION SENSITIVITY; INHERITANCE; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; URINARY TRACT INFECTIONS;

EID: 80051679794     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.100     Document Type: Review

References (194)

1. Hagberg, L. et al. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46, 839-844 (1984). (Pubitemid 15211093)
2. Frendeus, B. et al. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J. Exp. Med. 192, 881-890 (2000).
3. Hagberg, L., Briles, D. E. & Eden, C. S. Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to Gram-negative infections. J. Immunol. 134, 4118-4122 (1985). (Pubitemid 15029638)
4. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998). (Pubitemid 29001265)
5. Fischer, H., Yamamoto, M., Akira, S., Beutler, B. & Svanborg, C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur. J. Immunol. 36, 267-277 (2006). (Pubitemid 43257449)
6. Lundstedt, A. C. et al. A genetic basis of susceptibility to acute pyelonephritis. PLoS ONE 2, e825 (2007).
7. Ragnarsdottir, B. et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS ONE 5, e10734 (2010).
8. Picard, C. et al. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) 89, 403-425 (2010).
9. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (2003). (Pubitemid 36383736)
10. von Bernuth, H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691-696 (2008).
11. Doffinger, R. et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat. Genet. 27, 277-285 (2001). (Pubitemid 32201848)
12. Stamm, W. E. & Norrby, S. R. Urinary tract infections: disease panorama and challenges. J. Infect. Dis. 183 (Suppl. 1), S1-S4 (2001). (Pubitemid 32174135)
13. Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113 (Suppl. 1A), 5S-13S (2002). (Pubitemid 34756640)
14. Tenke, P. et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int. J. Antimicrob. Agents 31 (Suppl. 1), S68-S78 (2008).
15. Svanborg, C. et al. The 'innate' host response protects and damages the infected urinary tract. Ann. Med. 33, 563-570 (2001). (Pubitemid 34081493)
16. Stenquist, K. et al. Bacteriuria in pregnancy: frequency and risk of acquisition. Am. J. Epidemiol. 129, 372-379 (1989).
17. Wettergren, B., Jodal, U. & Jonasson, G. Epidemiology of bacteriuria during the first year of life. Acta Pediatr. Scand. 74, 925-933 (1985). (Pubitemid 16176812)
18. Lindberg, U., Claesson, I., Hanson, L. A. & Jodal, U. Asymptomatic bacteriuria in schoolgirls. I. Clinical and laboratory findings. Acta Paediatr. Scand. 64, 425-431 (1975).
19. Nordenstam, G., Branberg, Å., Odén, A., Svanborg- Edén, C. & Svanborg, A. Bacteriuria and mortality in an elderly population. N. Engl. J. Med. 314, 1152-1156 (1986). (Pubitemid 16138662)
20. Grio, R. et al. Asymptomatic bacteriuria in pregnancy: maternal and fetal complications. Panminerva Med. 36, 198-200 (1994).
21. Grio, R. et al. Asymptomatic bacteriuria in pregnancy: a diagnostic and therapeutic approach. Panminerva Med. 36, 195-197 (1994).
22. Hansson, S. et al. Follicular cystitis in girls with untreated asymtomatic bacteriuria. J. Urol. 143, 330-332 (1990). (Pubitemid 20066384)
23. Anderson, P. et al. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect. Immun. 59, 2915-2921 (1991).
24. Hagberg, L. et al. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect. Immun. 31, 564-570 (1981). (Pubitemid 11146229)
25. Wullt, B. et al. Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J. Urol. 159, 2057-2062 (1998). (Pubitemid 29190754)
26. Hull, R. et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J. Urol. 163, 872-877 (2000). (Pubitemid 30091635)
27. Sunden, F., Hakansson, L., Ljunggren, E. & Wullt, B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J. Urol. 184, 179-185 (2010).
28. Wullt, B. et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol. Microbiol. 38, 456-464 (2000).
29. Ragnarsdottir, B. et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J. Infect. Dis. 196, 475-484 (2007). (Pubitemid 47093899)
30. Zdziarski, J. et al. Host imprints on bacterial genomes-rapid, divergent evolution in individual patients. PLoS Pathog. 6, e1001078 (2010).
31. Lidin, J. G. et al. Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J. Infect. Dis. 136, 346-353 (1977).
32. Svanborg, C., Hanson, L. A., Jodal, U., Lindberg, U. & Akerlund, A. S. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet 1, 490-492 (1976).
33. Cirl, C. et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 14, 399-406 (2008). (Pubitemid 351499388)
34. Oelschlaeger, T. A., Dobrindt, U. & Hacker, J. Virulence factors of uropathogens. Curr. Opin. Urol. 12, 33-38 (2002). (Pubitemid 34033066)
35. Nielubowicz, G. R. & Mobley, H. L. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7, 430-441 (2010).
36. Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105-107 (2003). (Pubitemid 36801572)
37. Justice, S. S., Hunstad, D. A., Seed, P. C. & Hultgren, S. J. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl Acad. Sci. USA 103, 19884-19889 (2006). (Pubitemid 46037525)
38. Mysorekar, I. U. & Hultgren, S. J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl Acad. Sci. USA 103, 14170-14175 (2006). (Pubitemid 44452998)
39. Zdziarski, J., Svanborg, C., Wullt, B., Hacker, J. & Dobrindt, U. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect. Immun. 76, 695-703 (2008). (Pubitemid 351251741)
40. Roos, V., Schembri, M. A., Ulett, G. C. & Klemm, P. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152, 1799-1806 (2006).
41. Hedlund, M. et al. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol. Microbiol. 33, 693-703 (1999). (Pubitemid 29392650)
42. Samuelsson, P., Hang, L., Wullt, B., Irjala, H. & Svanborg, C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 72, 3179-3186 (2004). (Pubitemid 38697738)
43. Garmendia, J., Frankel, G. & Crepin, V. F. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect. Immun. 73, 2573-2585 (2005). (Pubitemid 40570322)
44. Mellies, J. L., Barron, A. M. & Carmona, A. M. Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation. Infect. Immun. 75, 4199-4210 (2007). (Pubitemid 47378075)
45. Viswanathan, V. K., Hodges, K. & Hecht, G. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat. Rev. Microbiol. 7, 110-119 (2009).
46. Leffler, H. & Svanborg-Edén, C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol. Lett. 8, 127-134 (1980). (Pubitemid 10057684)
47. Svanborg-Edén, C., Hanson, L., Jodal, U., Lindberg, U. & Sohl-Åkelund, A. Variable adherence to normal urinary tract epithelial cells of Escherichia coli strains associated with various forms of urinary tract infection. Lancet 1, 490-492 (1976).
48. Leffler, H. & Svanborg-Edén, C. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect. Immun. 34, 920-929 (1981). (Pubitemid 12247194)
49. Plos, K. et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J. Infect. Dis. 171, 625-631 (1995).
50. Lindberg, F., Lund, B., Johansson, L. & Normark, S. Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature 328, 84-87 (1987). (Pubitemid 17103588)
51. Linder, H., Engberg, I., Hoschültzky, H., Mattsby-Baltzer, I. & Svanborg, C. Adhesion-dependent activation of mucosal interleukin-6 production. Infect. Immun. 59, 4357-4362 (1991).
52. Bergsten, G. et al. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J. Infect. Dis. 189, 1734-1742 (2004). (Pubitemid 38648305)
53. Hedlund, M., Nilsson, Å., Duan, R. D. & Svanborg, C. Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P fimbriated Escherichia coli. Mol. Microbiol. 29, 1297-1306 (1998). (Pubitemid 28408851)
54. Hedlund, M., Svensson, M., Nilsson, A., Duan, R. D. & Svanborg, C. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J. Exp. Med. 183, 1037-1044 (1996).
55. Fischer, H. et al. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell. Microbiol. 9, 1239-1251 (2007). (Pubitemid 46547141)
56. Fischer, H. et al. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog. 6, e1001109 (2010).
57. Godaly, G. et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol. 69, 899-906 (2001). (Pubitemid 32577890)
58. Svanborg-Eden, C. et al. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect. Immun. 55, 1224-1232 (1987). (Pubitemid 17065677)
59. Mobley, H. L., Chippendale, G. R., Tenney, J. H., Hull, R. A. & Warren, J. W. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J. Clin. Microbiol. 25, 2253-2257 (1987). (Pubitemid 18008745)
60. Hultgren, S. J., Porter, T. N., Schaeffer, A. J. & Duncan, J. L. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect. Immun. 50, 370-377 (1985). (Pubitemid 16246248)
61. Schaeffer, A. J., Schwan, W. R., Hultgren, S. J. & Duncan, J. L. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect. Immun. 55, 373-380 (1987). (Pubitemid 17004115)
62. Wold, A. et al. Secretory immunoglobulin-A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58, 3073-3077 (1990). (Pubitemid 20267705)
63. Xie, B. et al. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J. Biol. Chem. 281, 14644-14653 (2006). (Pubitemid 43855168)
64. Malaviya, R., Gao, Z., Thankavel, K., van der Merwe, P. A. & Abraham, S. N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl Acad. Sci. USA 96, 8110-8115 (1999). (Pubitemid 29328416)
65. Eto, D. S., Jones, T. A., Sundsbak, J. L. & Mulvey, M. A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3, e100 (2007).
66. Pak, J., Pu, Y., Zhang, Z. T., Hasty, D. L. & Wu, X. R. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J. Biol. Chem. 276, 9924-9930 (2001).
67. Wright, K. J., Seed, P. C. & Hultgren, S. J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell. Microbiol. 9, 2230-2241 (2007). (Pubitemid 47250294)
68. Mulvey, M. A., Schilling, J. D. & Hultgren, S. J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69, 4572-4579 (2001). (Pubitemid 32574459)
69. Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329 (2007).
70. Shin, J. S., Gao, Z. & Abraham, S. N. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289, 785-788 (2000). (Pubitemid 30650200)
71. Baorto, D. M. et al. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389, 636-639 (1997). (Pubitemid 27446185)
72. Shin, J. S., Gao, Z. & Abraham, S. N. Bacteria-host cell interaction mediated by cellular cholesterol/glycolipid-enriched microdomains. Biosci. Rep. 19, 421-432 (1999). (Pubitemid 30169343)
73. McLean, G. W. et al. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat. Rev. Cancer 5, 505-515 (2005). (Pubitemid 40942827)
74. Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494-1497 (1998). (Pubitemid 28538612)
75. Klumpp, D. J. et al. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect. Immun. 74, 5106-5113 (2006). (Pubitemid 44300428)
76. Thumbikat, P. et al. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 5, e1000415 (2009).
77. Bishop, B. L. et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 13, 625-630 (2007). (Pubitemid 46828483)
78. Backhed, F., Meijer, L., Normark, S. & Richter-Dahlfors, A. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell. Microbiol. 4, 493-501 (2002). (Pubitemid 34993748)
79. Hedlund, M. et al. Type 1 fimbriae deliver an LPS-and TLR4-dependent activation signal to CD14-negative cells. Mol. Microbiol. 39, 542-552 (2001). (Pubitemid 32158136)
80. Schilling, J. D., Mulvey, M. A., Vincent, C. D., Lorenz, R. G. & Hultgren, S. J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166, 1148-1155 (2001). (Pubitemid 32060274)
81. Song, J., Bishop, B. L., Li, G., Duncan, M. J. & Abraham, S. N. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1, 287-298 (2007). (Pubitemid 46865609)
82. Bergsten, G., Wullt, B., Schembri, M. A., Leijonhufvud, I. & Svanborg, C. Do type 1 fimbriae promote inflammation in the human urinary tract? Cell. Microbiol. 9, 1766-1781 (2007). (Pubitemid 46958802)
83. Connell, H. et al. Type 1 fimbrial adhesion enhances Escherichia coli virulence for the urinary tract. Proc. Natl Acad. Sci. USA 93, 9827-9832 (1996). (Pubitemid 26296694)
84. Frendeus, B., Godaly, G., Hang, L., Karpman, D. & Svanborg, C. Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis. J. Infect. Dis. 183 (Suppl. 1), S56-S60 (2001). (Pubitemid 32174149)
85. Ragnarsdottir, B. et al. TLR-and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur. J. Clin. Invest. 38 (Suppl. 2), 12-20 (2008).
86. Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl Acad. Sci. USA 101, 1333-1338 (2004). (Pubitemid 38182689)
87. Yadav, M. et al. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6, e1001120 (2010).
88. Hang, L., Frendeus, B., Godaly, G. & Svanborg, C. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J. Infect. Dis. 182, 1738-1748 (2000).
89. Rh-/- mice. Kidney Int. 67, 103-110 (2005). (Pubitemid 40019231)
90. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001). (Pubitemid 32368048)
91. Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658 (2006). (Pubitemid 44298214)
92. Godaly, G. et al. Role of fimbriae-mediated adherence for neutrophil migration across Escherichia coli-infected epithelial cell layers. Mol. Microbol. 30, 725-735 (1998). (Pubitemid 28528592)
93. Otto, G., Burdick, M., Strieter, R. & Godaly, G. Chemokine response to febrile urinary tract infection. Kidney Int. 68, 62-70 (2005). (Pubitemid 43181364)
94. Agace, W. W., Hedges, S. R., Ceska, M. & Svanborg, C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 92, 780-785 (1993). (Pubitemid 23262398)
95. Svensson, M., Irjala, H., Svanborg, C. & Godaly, G. Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int. 74, 81-90 (2008). (Pubitemid 351841886)
96. -/- mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 178, 4717-4720 (2007). (Pubitemid 46595250)
97. Zhang, D. et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303, 1522-1526 (2004). (Pubitemid 38314423)
98. Yarovinsky, F. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626-1629 (2005). (Pubitemid 40807512)
99. Ørskov, F., Ørskov, I., Jann, B. & Jann, K. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1, 887 (1980).
100. Cavallone, D., Malagolini, N. & Serafini-Cessi, F. Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart. Biochem. Biophys. Res. Commun. 280, 110-114 (2001). (Pubitemid 32917484)
101. Schmid, M. et al. Uromodulin facilitates neutrophil migration across renal epithelial monolayers. Cell. Physiol. Biochem. 26, 311-318 (2010).
102. Bates, J. M. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791-797 (2004).
103. Raffi, H. S., Bates, J. M. Jr, Laszik, Z. & Kumar, S. Tamm-horsfall protein protects against urinary tract infection by proteus mirabilis. J. Urol. 181, 2332-2338 (2009).
104. Dou, W. et al. Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections. Am. J. Physiol. Renal Physiol. 289, F49-F60 (2005). (Pubitemid 40863572)
105. El-Achkar, T. M., Plotkin, Z., Marcic, B. & Dagher, P. C. Sepsis induces an increase in thick ascending limb Cox-2 that is TLR4 dependent. Am. J. Physiol. Renal Physiol. 293, F1187-F1196 (2007). (Pubitemid 47583952)
106. Saemann, M. D. et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J. Clin. Invest. 115, 468-475 (2005). (Pubitemid 40385489)
107. Boman, H. Antibacterial peptides: key components needed in immunity. Cell 65, 205-207 (1991). (Pubitemid 121006052)
108. Chromek, M. et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641 (2006). (Pubitemid 43865231)
109. Hawn, T. R. et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198, 1563-1572 (2003). (Pubitemid 37467170)
110. Hawn, T. R. et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS ONE 4, e5990 (2009).
111. Rehli, M. et al. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-9781 (2000). (Pubitemid 30185212)
112. Arbour, N. C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187-191 (2000). (Pubitemid 30394990)
113. Allen, A. et al. Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J. 22, 1018-1019 (2003). (Pubitemid 37445083)
114. Read, R. C. et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184, 640-642 (2001). (Pubitemid 32783557)
115. Karoly, E. et al. Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr. Res. 61, 371-374 (2007).
116. Yin, X. et al. Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS ONE 5, e14223 (2010).
117. Calvano, J. E. et al. Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). Clin. Immunol. 121, 186-190 (2006). (Pubitemid 44572971)
118. Marsik, C. et al. The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin. Chem. 51, 2178-2180 (2005). (Pubitemid 41532642)
119. Ferwerda, B. et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl Acad. Sci. USA 104, 16645-16650 (2007). (Pubitemid 350211070)
120. Lichtinger, M., Ingram, R., Hornef, M., Bonifer, C. & Rehli, M. Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J. Biol. Chem. 282, 26874-26883 (2007). (Pubitemid 47501897)
121. Roger, T. et al. Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 387, 355-365 (2005). (Pubitemid 40571221)
122. Roger, T., David, J., Glauser, M. P. & Calandra, T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924 (2001). (Pubitemid 34024744)
123. Hawn, T. R. et al. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS ONE 4, e8300 (2009).
124. Schroder, N. W. et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175, 2534-2540 (2005). (Pubitemid 41113865)
125. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C. & Wood, W. I. Structure and functional expression of a human interleukin-8 receptor. Science 253, 1278-1280 (1991). (Pubitemid 21917277)
126. Murphy, P. M. & Tiffany, H. L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253, 1280-1283 (1991). (Pubitemid 21917278)
127. Murdoch, C. & Finn, A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032-3043 (2000). (Pubitemid 30321151)
128. Artifoni, L. et al. Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J. Urol. 177, 1102-1106 (2007). (Pubitemid 46216366)
129. Smithson, A. et al. Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin. Diagn. Lab. Immunol. 12, 1358-1363 (2005). (Pubitemid 41818942)
130. Centi, S. et al. Upper urinar y tract infections are associated with RANTES promoter polymorphism. J. Pediatr. 157, 1038-1040 e1 (2010).
131. Hussein, A., Askar, E., Elsaeid, M. & Schaefer, F. Functional polymorphisms in transforming growth factor-beta-1 (TGFβ1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol. Dial. Transplant. 25, 779-785 (2010).
132. Grainger, D. J. et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Gen. 8, 93-97 (1999). (Pubitemid 29039053)
133. Cotton, S. A., Gbadegesin, R. A., Williams, S., Brenchley, P. E. & Webb, N. J. Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 61, 61-67 (2002). (Pubitemid 34075131)
134. Solari, V., Owen, D. & Puri, P. Association of transforming growth factor-β1 gene polymorphism with reflux nephropathy. J. Urol. 174, 1609-1611 (2005). (Pubitemid 41318638)
135. Yim, H. E., Bae, I. S., Yoo, K. H., Hong, Y. S. & Lee, J. W. Genetic control of VEGF and TGF-β1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux. Pediatr. Res. 62, 183-187 (2007). (Pubitemid 47205719)
136. Hughes, L. B. et al. Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes Immun. 5, 641-647 (2004). (Pubitemid 40045302)
137. Lundstedt, A. C. et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J. Infect. Dis. 195, 1227-1234 (2007).
138. Scholes, D. et al. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 182, 1177-1182 (2000).
139. Stauffer, C. M. et al. Family history and behavioral abnormalities in girls with recurrent urinary tract infections: a controlled study. J. Urol. 171, 1663-1665 (2004). (Pubitemid 38365460)
140. Scholes, D. et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J. Urol. 184, 564-569 (2010).
141. Svenson, S. B. et al. P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection 11, 61-67 (1983).
142. Lomberg, H., Jodal, U., Svanborg-Edén, C., Leffler, H. & Samuelsson, B. P1 blood group and urinary tract infection. Lancet 1, 551-552 (1981).
143. Lomberg, H. et al. Correlation of P blood group phenotype, vesicoureteral reflux and bacterial attachment in patients with recurrent pyelonephritis. N. Engl. J. Med. 308, 1189-1192 (1983). (Pubitemid 13130838)
144. Stapleton, A., Nudelman, E., Clausen, H., Hakomori, S. & Stamm, W. E. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J. Clin. Invest. 90, 965-972 (1992).
145. Lindstedt, R. et al. The receptor repertoire defines the host range for attaching Escherichia coli recognizing globo-A. Infect. Immun. 59, 1086-1092 (1991).
146. Svensson, M. et al. Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection. J. Infect. Dis. 183 (Suppl. 1), S70-S73 (2001). (Pubitemid 32174152)
147. Svanborg Eden, C., Briles, D., Hagberg, L., McGhee, J. & Michalec, S. Genetic factors in host resistance to urinary tract infection. Infection 12, 118-123 (1984).
148. Hopkins, W. J., James, L. J., Balish, E. & Uehling, D. T. Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection. J. Urol. 149, 922-925 (1993). (Pubitemid 23111113)
149. Jones-Carson, J., Balish, E. & Uehling, D. T. Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. J. Urol. 161, 338-341 (1999). (Pubitemid 29422358)
150. Sivick, K. E., Schaller, M. A., Smith, S. N. & Mobley, H. L. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 184, 2065-2075 (2010).
151. Hodson, C. J. & Edwards, D. Chronic pyelonephritis and vesico-ureteric reflex. Clin. Radiol. 11, 219-231 (1960).
152. Ransley, P. & Risdon, R. Reflux and renal scarring. Br. J. Radiol. 51, (Suppl. 14), 1-38 (1978).
153. Stokland, E., Hellstrom, M., Jacobsson, B., Jodal, U. & Sixt, R. Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy. J. Pediatr. 129, 815-820 (1996). (Pubitemid 27500358)
154. Stokland, E., Hellstrom, M., Jacobsson, B., Jodal, U. & Sixt, R. Evaluation of DMSA scintigraphy and urography in assessing both acute and permanent renal damage in children. Acta Radiologica 39, 447-452 (1998). (Pubitemid 128451565)
155. Kass, E. J., Kernen, K. M. & Carey, J. M. Paediatric urinary tract infection and the necessity of complete urological imaging. BJU Int. 86, 94-96 (2000). (Pubitemid 30420772)
156. Craig, J. C., Irwig, L. M., Knight, J. F. & Roy, L. P. Does treatment of vesicoureteric reflux in childhood prevent end-stage renal disease attributable to reflux nephropathy? Pediatrics 105, 1236-1241 (2000). (Pubitemid 30346892)
157. Lomberg, H., Hellström, M., Jodal, U. & Svanborg-Edén, C. Renal scarring and non-attaching bacteria. Lancet 2, 1341 (1986).
158. Hodson, C., Maling, T., McManamon, P. & Lewis, M. The pathogenesis of reflux nephropathy (chronic atrophic pyelonephritis). Br. J. Radiol. 48 (Suppl. 13), 1-26 (1975).
159. Mebust, W. K. & Foret, J. D. Vesicoureteral reflux in identical twins. J. Urol. 108, 635-636 (1972).
160. Nishimura, H. et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol. Cell 3, 1-10 (1999). (Pubitemid 29292472)
161. Oshima, K. et al. Angiotensin type II receptor expression and ureteral budding. J. Urol. 166, 1848-1852 (2001).
162. Yu, O. H., Murawski, I. J., Myburgh, D. B. & Gupta, I. R. Overexpression of RET leads to vesicoureteric reflux in mice. Am. J. Physiol. Renal Physiol. 287, F1123-F1130 (2004). (Pubitemid 39517012)
163. Hu, P. et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J. Cell Biol. 151, 961-972 (2000).
164. Kong, X. T. et al. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J. Cell Biol. 167, 1195-1204 (2004).
165. Yoneda, A., Cascio, S., Oue, T., Chertin, B. & Puri, P. Risk factors for the development of renal parenchymal damage in familial vesicoureteral reflux. J. Urol. 168, 1704-1707 (2002). (Pubitemid 35034060)
166. Savvidou, A. et al. Polymorphisms of the TNF-α and ACE genes, and renal scarring in infants with urinary tract infection. J. Urol. 183, 684-687 (2010).
167. Ozen, S. et al. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: importance of ACE polymorphism. Am. J. Kidney Dis.34, 140-145 (1999). (Pubitemid 29318808)
168. Haszon, I. et al. ACE gene polymorphism and renal scarring in primary vesicoureteric reflux. Pediatr. Nephrol. 17, 1027-1031 (2002). (Pubitemid 36097646)
169. Ohtomo, Y. et al. Angiotensin converting enzyme gene polymorphism in primary vesicoureteral reflux. Pediatr. Nephrol. 16, 648-652 (2001). (Pubitemid 32725434)
170. Rigoli, L. et al. Angiotensin-converting enzyme and angiotensin type 2 receptor gene genotype distributions in Italian children with congenital uropathies. Pediatr. Res. 56, 988-993 (2004). (Pubitemid 39552784)
171. Park, H. W. et al. Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children. Nephron 86, 52-55 (2000).
172. Ece, A., Tekes, S., Gurkan, F., Bilici, M. & Budak, T. Polymorphisms of the angiotensin converting enzyme and angiotensin II type 1 receptor genes and renal scarring in non-uropathic children with recurrent urinary tract infection. Nephrology (Carlton) 10, 377-381 (2005). (Pubitemid 41725514)
173. Sekerli, E., Katsanidis, D., Vavatsi, N., Makedou, A. & Gatzola, M. ACE gene insertion/deletion polymorphism and renal scarring in children with urinary tract infections. Pediatr. Nephrol. 24, 1975-1980 (2009).
174. Liu, K. P., Lin, C. Y., Chen, H. J., Wei, C. F. & Lee-Chen, G. J. Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr. Nephrol. 19, 594-601 (2004).
175. Cho, S. J. & Lee, S. J. ACE gene polymorphism and renal scar in children with acute pyelonephritis. Pediatr. Nephrol. 17, 491-495 (2002). (Pubitemid 36097310)
176. Conte, M. L. et al. A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity. Pediatr. Nephrol. 23, 587-595 (2008).
177. Cordell, H. J. et al. Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux. J. Am. Soc. Nephrol. 21, 113-123 (2010).
178. Lore, F., Talidis, F., Di Cairano, G. & Renieri, A. Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations. J. Int. Med. 250, 37-42 (2001). (Pubitemid 34208936)
179. Yang, Y., Houle, A. M., Letendre, J. & Richter, A. RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec. Hum. Mutat. 29, 695-702 (2008). (Pubitemid 351614594)
180. Darlow, J. M., Molloy, N. H., Green, A. J., Puri, P. & Barton, D. E. The increased incidence of the RET p.Gly691Ser variant in French-Canadian vesicoureteric reflux patients is not replicated by a larger study in Ireland. Hum. Mutat. 30, E612-E617 (2009).
181. Jenkins, D. et al. Mutation analyses of uroplakin II in children with renal tract malformations. Nephrol. Dial. Transplant. 21, 3415-3421 (2006). (Pubitemid 44817089)
182. Jenkins, D. et al. De novo uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J. Am. Soc. Nephrol. 16, 2141-2149 (2005). (Pubitemid 41716446)
183. Kelly, H. et al. Uroplakin III is not a major candidate gene for primary vesicoureteral reflux. Eur. J. Hum. Genet. 13, 500-502 (2005). (Pubitemid 40520942)
184. Haraoka, M. et al. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 180, 1220-1229 (1999). (Pubitemid 30070207)
185. Hopkins, W., Gendron-Fitzpatrick, A., McCarthy, D. O., Haine, J. E. & Uehling, D. T. Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infect. Immun. 64, 1369-1372 (1996). (Pubitemid 26102402)
186. Mo, L. et al. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am. J. Physiol. Renal Physiol. 286, F795-F802 (2004). (Pubitemid 38365099)
187. Tabel, Y., Berdeli, A. & Mir, S. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int. J. Immunogenet. 34, 399-405 (2007). (Pubitemid 350126007)
188. Yim, H. E. et al. Genetic polymorphism of the renin-angiotensin system on the development of primary vesicoureteral reflux. Am. J. Nephrol. 24, 178-187 (2004). (Pubitemid 38456628)
189. Spasojevic-Dimitrijeva, B., Zivkovic, M., Stankovic, A., Stojkovic, L. & Kostic, M. The IL-6-174G/C polymorphism and renal scarring in children with first acute pyelonephritis. Pediatr. Nephrol. 25, 2099-2106 (2010).
190. Lee-Chen, G. J. et al. Significance of the tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int. 65, 1467-1472 (2004).
191. Kowalewska-Pietrzak, M., Klich, I. & Mlynarski, W. TGF-β1 gene polymorphisms and primary vesicoureteral reflux in childhood. Pediatr. Nephrol. 23, 2195-2200 (2008).
192. Kuroda, S., Solari, V. & Puri, P. Association of transforming growth factor-β1 gene polymorphism with familial vesicoureteral reflux. J. Urol. 178, 1650-1653 (2007). (Pubitemid 47368518)
193. Jiang, S. et al. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int. 66, 10-19 (2004). (Pubitemid 38870077)
194. Kuroda, S. & Puri, P. Lack of association of IL8 gene polymorphisms with familial vesico-ureteral reflux. Pediatr. Surg. Int. 23, 441-445 (2007). (Pubitemid 46626230)